Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.
UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.
The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.
Carnegie Mellon-linked Duolingo raised $521m in an upsized offering and saw its shares rise 36% on their first day.
UC Berkeley’s cancer therapy developer priced a $304m initial public offering at the top of its range.
Yale University is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.
Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.